Viral Persistence and Chronic Immunopathology in the Adult Central Nervous System following Coxsackievirus Infection during the Neonatal Period
Authors:
Open Access
- 15 September 2009
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (18) , 9356-9369
Abstract
Coxsackieviruses are significant human pathogens, and the neonatal central nervous system (CNS) is a major target for infection. Despite the extreme susceptibility of newborn infants to coxsackievirus infection and viral tropism for the CNS, few studies have been aimed at determining the long-term consequences of infection on the developing CNS. We previously described a neonatal mouse model of coxsackievirus B3 (CVB3) infection and determined that proliferating stem cells in the CNS were preferentially targeted. Here, we describe later stages of infection, the ensuing inflammatory response, and subsequent lesions which remain in the adult CNS of surviving animals. High levels of type I interferons and chemokines (in particular MCP-5, IP10, and RANTES) were upregulated following infection and remained at high levels up to day 10 postinfection (p.i). Chronic inflammation and lesions were observed in the hippocampus and cortex of surviving mice for up to 9 months p.i. CVB3 RNA was detected in the CNS up to 3 months p.i at high abundance (∼106genomes/mouse brain), and viral genomic material remained detectable in culture after two rounds of in vitro passage. These data suggest that CVB3 may persist in the CNS as a low-level, noncytolytic infection, causing ongoing inflammatory lesions. Thus, the effects of a relatively common infection during the neonatal period may be long lasting, and the prognosis for newborn infants recovering from acute infection should be reexplored.Keywords
This publication has 63 references indexed in Scilit:
- Deletions within the 5′UTR of coxsackievirus B3: Consequences for virus translation and replicationVirology, 2006
- Inhibition of Protein Trafficking by Coxsackievirus B3: Multiple Viral Proteins Target a Single OrganelleJournal of Virology, 2006
- 5′-Terminal Deletions Occur in Coxsackievirus B3 during Replication in Murine Hearts and Cardiac Myocyte Cultures and Correlate with Encapsidation of Negative-Strand Viral RNAJournal of Virology, 2005
- Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolateJournal of General Virology, 2005
- Evidence for coxsackievirus infection in primary Sjögren's syndromeArthritis & Rheumatism, 2004
- Myocarditis, Microbes and AutoimmunityAutoimmunity, 2004
- Proteasome Inhibition Reduces Coxsackievirus B3 Replication in Murine CardiomyocytesThe American Journal of Pathology, 2003
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Interferon-Independent, Human Immunodeficiency Virus Type 1 gp120-Mediated Induction of CXCL10/IP-10 Gene Expression by Astrocytes In Vivo and In VitroJournal of Virology, 2001
- Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.Journal of Clinical Investigation, 1998